Menopausal hormone therapy no longer has the highest-level warning label about the risk of breast cancer, opening a gray area on who would benefit most from treatment.

The summer issue of Cancer Today includes articles about integrating patient-reported outcomes into clinical research and care, advances in preventing and treating graft-versus-host disease, researchers’ efforts to better understand the mechanisms of treatment resistance, advice about divulging a cancer diagnosis when dating, and more.
The post Cancer Today’s Summer 2026 Issue: Using Patient-reported Outcomes to Address Side Effects, Preventing Graft-versus-host Disease, and More appeared first on American Association for Cancer Research (AACR).

At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global resources and expertise to drive rare cancer research forward.
The post The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress appeared first on American Association for Cancer Research (AACR).

Cancer survivors often experience cognitive, visual or physical challenges that hinder software use. Better designs can help.

Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on pancreatic cancer vaccines and explains why cancer interception in individuals at high risk is the new frontier of the field.
The post From Treatment to Prevention: How Vaccines Are Reshaping the Fight Against Pancreatic Cancer appeared first on American Association for Cancer Research (AACR).

Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR Annual Meeting 2026 by Shuguang Leng, MBBS, PhD, and Qizhen Wu, PhD, both of the University of New Mexico Comprehensive Cancer Center. Amid bigger U.S. wildfires, wildfire smoke’s impacts on human health are increasingly relevant.
The post Catching the Drift: How Wildfire Smoke Plumes May Increase Cancer Risk appeared first on American Association for Cancer Research (AACR).

Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.

Cancer researchers—including Elizabeth M. Jaffee, MD, FAACR, of the Sidney Kimmel Cancer Center at Johns Hopkins; Robert H. Vonderheide, MD, DPhil, FAACR, of the Abramson Cancer Center of the University of Pennsylvania; Kornelia Polyak, MD, PhD, FAACR, of Dana-Farber Cancer Institute and Harvard Medical School; Cornelia Ulrich, PhD, of the Huntsman Cancer Institute and University of Utah; Electra D. Paskett, PhD, FAACR, of The Ohio State University, and Anna Barker, PhD, FAACR, of the Ellison Medical Institute—explain how certain provisions of the White House Office of Management and Budget’s proposal to change how federal grants are awarded and managed would be harmful to U.S. scientific and medical innovation.
The post Cancer Researchers Explain How OMB’s Proposed Changes to Federal Grantmaking Will Cause Delays, Reduce Transparency, and Undermine Merit-based Processes appeared first on American Association for Cancer Research (AACR).

Science works at a much slower pace than social media, opening a large window for early findings to be taken at face value and misinformation to spread.

After surviving brain cancer, former competitive cyclist Chris Baccash dedicated his life to helping others. Baccash now uses his passion for cycling to make an impact, including by participating in the upcoming Philadelphia Cycling Classic Charity Ride for AACR.
The post Chris Baccash: A Brain Cancer Survivor Who Is Cycling to Make a Difference appeared first on American Association for Cancer Research (AACR).